Asymmetry Capital Management’s AstraZeneca AZN Stock Holding History

Asymmetry Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-58,121	Closed	-$6.98M	–	27
2021 Q3	$6.98M	Sell	58,121 -29,884	-34%	-$3.48M	4.2%	12
2021 Q2	$10.5M	Sell	88,005 -21,454	-20%	-$2.35M	7.25%	2
2021 Q1	$10.9M	Buy	+109,459	New	+$11M	5.63%	8
2017 Q2	–	Sell	-12,405	Closed	-$773K	–	29
2017 Q1	$773K	Buy	+12,405	New	+$722K	1.08%	23

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Asymmetry Capital Management's AZN Position: Q4 2021 in Review

Asymmetry Capital Management sold out of AstraZeneca (AZN) in Q4 2021, closing a stake of 58,121 shares — an estimated $6.98M sold.

Asymmetry Capital Management first reported a position in AZN in Q1 2017 and held it in 4 quarters. The position peaked at $10.9M in Q1 2021. 949 funds tracked by Wall St. Rank hold AZN as of Q4 2021.

Asymmetry Capital Management reported no remaining AstraZeneca position as of Q4 2021 after selling out during the quarter.
Asymmetry Capital Management sold 58,121 AstraZeneca shares in Q4 2021, an estimated $6.98M.
Asymmetry Capital Management first reported a position in AstraZeneca in Q1 2017 and held it in 4 quarters.
Asymmetry Capital Management's AstraZeneca position peaked at $10.9M in Q1 2021.
949 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2021.

Based on Asymmetry Capital Management's 13F filing for Q4 2021, filed 19 Jan 2022.